Farinati F - Search Results

1

The changing scenario of hepatocellular carcinoma over the last two decades in Italy.

Santi V, Buccione D, Di Micoli A, Fatti G, Frigerio M, Farinati F, Del Poggio P, Rapaccini G, Di Nolfo MA, Benvegnù L, Zoli M, Borzio F, Giannini EG, Caturelli E, Chiaramonte M, Bernardi M, Trevisani F. Santi V, et al. Among authors: farinati f. J Hepatol. 2012 Feb;56(2):397-405. doi: 10.1016/j.jhep.2011.05.026. Epub 2011 Jul 12. J Hepatol. 2012. PMID: 21756850 Free article.

2

Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma.

Farinati F, De Maria N, Fornasiero A, Salvagnini M, Fagiuoli S, Chiaramonte M, Naccarato R. Farinati F, et al. Dig Dis Sci. 1992 May;37(5):659-62. doi: 10.1007/BF01296419. Dig Dis Sci. 1992. PMID: 1373360 Clinical Trial.

3

Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical features.

Farinati F, Fagiuoli S, De Maria N, Chiaramonte M, Aneloni V, Ongaro S, Salvagnini M, Naccarato R. Farinati F, et al. J Hepatol. 1992 Mar;14(2-3):183-7. doi: 10.1016/0168-8278(92)90156-j. J Hepatol. 1992. PMID: 1380021

4

Risk of hepatocellular carcinoma in alcoholic cirrhosis.

Farinati F, Fagiuoli S, de Maria N, Zotti S, Chiaramonte M, Salvagnini M, Naccarato R. Farinati F, et al. Liver. 1991 Jun;11(3):190-1. doi: 10.1111/j.1600-0676.1991.tb00514.x. Liver. 1991. PMID: 1653387 No abstract available.

5

Hormonal treatment of hepatocellular carcinoma.

Farinati F, De Maria N, Chiaramonte M, Fagiuoli S, Salvagnini M, Naccarato R. Farinati F, et al. J Hepatol. 1991 May;12(3):402. doi: 10.1016/0168-8278(91)90847-5. J Hepatol. 1991. PMID: 1658123 No abstract available.

6

Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen.

Farinati F, Salvagnini M, de Maria N, Fornasiero A, Chiaramonte M, Rossaro L, Naccarato R. Farinati F, et al. J Hepatol. 1990 Nov;11(3):297-301. doi: 10.1016/0168-8278(90)90211-9. J Hepatol. 1990. PMID: 1705274 Clinical Trial.

7

Diagnostic and prognostic value of the determination of the aminopropeptide of type III procollagen in patients with primary liver cancer.

Farinati F, Annoni G, Donato MF, Nardelli P, Bertozzo A, De Maria N, Zotti S, Salvagnini M, Martinez D, Naccarato R. Farinati F, et al. J Gastroenterol Hepatol. 1990 Nov-Dec;5(6):633-8. doi: 10.1111/j.1440-1746.1990.tb01117.x. J Gastroenterol Hepatol. 1990. PMID: 1966598

8

Hepatocellular carcinoma in primary biliary cirrhosis.

Farinati F, Floreani A, De Maria N, Fagiuoli S, Naccarato R, Chiaramonte M. Farinati F, et al. J Hepatol. 1994 Sep;21(3):315-6. doi: 10.1016/s0168-8278(05)80307-1. J Hepatol. 1994. PMID: 7530737

9

Fasting hyperglycaemia following trans-catheter arterial chemo-embolization for hepatocellular carcinoma in cirrhosis.

Farinati F, Rinaldi M, Del Prato S, Lana S, De Maria N, Paleari D, Marafin C, Naccarato R. Farinati F, et al. Ital J Gastroenterol Hepatol. 1997 Oct;29(5):427-33. Ital J Gastroenterol Hepatol. 1997. PMID: 9494852

10

Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.

Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R. Chiaramonte M, et al. Among authors: farinati f. Cancer. 1999 May 15;85(10):2132-7. Cancer. 1999. PMID: 10326690

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

404 results

Search Page